Correlation Between Achilles Therapeutics and Ovid Therapeutics

Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Ovid Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Ovid Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Achilles Therapeutics PLC and Ovid Therapeutics, you can compare the effects of market volatilities on Achilles Therapeutics and Ovid Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Ovid Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Ovid Therapeutics.

Diversification Opportunities for Achilles Therapeutics and Ovid Therapeutics

0.15

Correlation Coefficient

Achilles Therapeutics  Ovid Therapeutics

Average diversification

The 3 months correlation between Achilles and Ovid is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Ovid Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ovid Therapeutics and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Ovid Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ovid Therapeutics has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Ovid Therapeutics go up and down completely randomly.

Pair Corralation between Achilles Therapeutics and Ovid Therapeutics

Given the investment horizon of 90 days Achilles Therapeutics PLC is expected to generate 1.22 times more return on investment than Ovid Therapeutics. However, Achilles Therapeutics is 1.22 times more volatile than Ovid Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Ovid Therapeutics is currently generating about 0.04 per unit of risk. If you would invest  71.00  in Achilles Therapeutics PLC on September 3, 2024 and sell it today you would earn a total of  37.00  from holding Achilles Therapeutics PLC or generate 52.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Achilles Therapeutics PLC  vs.  Ovid Therapeutics

Achilles Therapeutics PLC

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Achilles Therapeutics PLC are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical indicators, Achilles Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Ovid Therapeutics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Ovid Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak forward indicators, Ovid Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Achilles Therapeutics and Ovid Therapeutics

The main advantage of trading using opposite Achilles Therapeutics and Ovid Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Ovid Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ovid Therapeutics will offset losses from the drop in Ovid Therapeutics' long position.

The idea behind Achilles Therapeutics PLC and Ovid Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.